DigiNepal

CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway

Oncology Research · Shi Zong, Kaichen Wang, Yonggang Wang · 2026

  • EnglishRead in your language
  • CitedEvery fact sourced
  • Ad-freeNo ads, no tracking

Quick facts

Author
Shi Zong, Kaichen Wang, Yonggang Wang ref
Published
ref
Publisher
Tech Science Press ref
Journal
Oncology Research ref

Questions

Who wrote CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway?
CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway was written by Shi Zong, Kaichen Wang, Yonggang Wang.
When was CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway first published?
CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway was first published in 2026.

Sources

  1. Publisher record (DOI, via Crossref)

Last updated · facts checked 14 October 2026

Cite this page

"CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway". DigiNepal. Last updated 14 October 2026. https://diginpl.com/books/paper-or-2026-084842. Retrieved 14 November 2026.

Machine-readable versions: JSON · Markdown

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.084842.

← Books